Home › NDC Lookup › Ingredients › Methenamine, Sodium Salicylate, And Phen... › 73712-0501-24
All-In-One UTI Emergency Kit Methenamine, Sodium Salicylate, and Phenazopyridine Hydrochloride Kit — NDC 73712-0501-24 package photo

All-In-One UTI Emergency Kit Methenamine, Sodium Salicylate, and Phenazopyridine Hydrochloride Kit

by Bonafide Health, LLC dba Uqora · 1 KIT in 1 CARTON (73712-501-24) * 12 TABLET in 1 BLISTER PACK (73712-804-12) * 1 BLISTER PACK in 1 CARTON (73712-114-12) / 12 TABLET in 1 BLISTER PACK
NDC 73712-0501-24
🏷️ FDA NDC (as labeled) 73712-501-24 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 73712-501-24
Product NDC 73712-501
11-digit billing NDC 73712050124
RxCUI 1094147, 1489932
SPL Set ID 434652a1-583e-d6f7-e063-6394a90aab8a
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2022-10-17
Dosage form KIT
Why two NDCs? The FDA registers this code as 73712-501-24 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73712-0501-24. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Other urologicals class.

Drug family (ATC) Other urologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerBonafide Health, LLC dba Uqora
Labeler code73712
First marketedOct 2022
Product typeHuman Otc Drug
Portfolio3 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an unapproved over-the-counter kit containing three active ingredients commonly used in urinary tract symptom relief products. Methenamine functions as a urinary antiseptic, sodium salicylate is typically used for pain and inflammation, and phenazopyridine hydrochloride is commonly used to reduce urinary discomfort. The kit is intended as an at-home product, though it is marketed without an FDA-approved application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color red / brown
ShapeOval
Imprintp99
Size9 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

From the label’s inactive-ingredient sectionInactive Ingredients UTI Infection Control benzoic acid, croscarmellose sodium, fd&c red #40, fd&c yellow #6, hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate copolymer, microcrystalline cellulose, silicon dioxide, stearic acid, sodium bicarbonate, sodium lauryl sulfate, talc, titanium dioxide, triacetin, triethyl citrate UTI Pain Relief corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodium starch glycolate, talc and triacetin.

This is label-wide narrative text, not a normalized exact-product ingredient list. A label can cover multiple strengths or packages.

Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
All-In-One UTI Emergency Kitthis 73712-0501-24 Bonafide 12 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2022
On the market since
Oct 2022
📍
2026
Currently FDA-listed
4 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
73712-0501-24 You're viewing this 1 KIT in 1 CARTON (73712-501-24) * 12 TABLET in 1 BLISTER PACK (73712-804-12) * 1 BLISTER PACK in 1 CARTON (73712-114-12) / 12 TABLET in 1 BLISTER PACK 2022-10-17 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application Kit / multi-component package

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

Kit / multi-component package

This NDC identifies a kit — a package containing more than one component. Structured data (pricing, ingredients, equivalents) is often reported per component rather than for the kit NDC itself, which can make this page look thinner than the components' own pages.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 73712-501-24, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 73712-0501-24, written without dashes as 73712050124. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 73712-0501-24, the first segment (73712) is the labeler code FDA assigned to Bonafide Health, LLC dba Uqora; the middle segment (0501) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (24) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Bonafide Health, LLC dba Uqora. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Bonafide Health, LLC dba Uqora is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 39 words ▾

Uses UTI Infection Control Temporarily relieves: pain and burning frequency and urgency of urination UTI Pain Relief Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.

⏱️ Dosage and Administration 100 words ▾

Directions UTI Infection Control Adults and children 12 years and over: take 2 tablets with a full glass of water 3 times a day. Drink plenty of fluids. Do not use for more than a 3 day period unless directed by a doctor.

Children under 12 years : ask a doctor. UTI Pain Relief Adults and children 12 years and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed Do not use for more than 2 days (12 tablets) without consulting a doctor. Children under 12 years: consult a doctor

⚠️ Warnings ~3 min read ▾

Warnings Reye's Syndrome (UTI Infection Control Only) Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness. Stomach Bleeding Warning (UTI Infection Control Only) Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding.

The chance is higher if you are 60 or older have stomach ulcers or bleeding problems take a blood thinning (anticoagulant) or steroid drug take other drugs containing an NSAID (aspirin, ibuprofen, naproxen, or others) have 3 or more alcoholic drinks every day while using this product take more or for a longer time than directed Do Not Exceed (UTI Pain Relief Only) Do not exceed recommended dosage Do Not Use Do not use : If you are allergic to salicylates (including aspirin) ( UTI Infection Control only ) If you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your doctor ( UTI Pain Relief only) Ask A Doctor Before Use Ask a doctor before use if you have: frequent, burning urination for the first time (UTI Infection Control only) the stomach bleeding warning applying to you (UTI Infection Control only) history of stomach problems, such as heartburn (UTI Infection Control only) high blood pressure (UTI Infection Control only) heart disease (UTI Infection Control only) liver cirrhosis (UTI Infection Control only) bleeding problems (UTI Infection Control only) diuretic use (UTI Infection Control only) ulcers (UTI Infection Control only) kidney disease a sodium restricted diect (UTI Infection Control only) reached age 60 or older (UTI Infection Control only) allergies to foods, preservatives or dyes (UTI Pain Relief only) had a hypersensitive reaction to phenazopyridine (UTI Pain Relief only) Ask A Doctor Or Pharmacist Before Use (UTI Infection Control Only) Ask a doctor or pharmacist before use if you are: taking any other drug containing an NSAID (prescription or non-prescription) taking a blood thinning (anticoagulant), steroid, diabetes, gout or arthritis drug When Using This Product When using this product: do not take more than the recommended dosage (UTI Infection Control only) stomach upset may occur, taking this product with or after meals may reduce stomach upset (UTI Pain Relief only) your urine will become reddish-orange in color.

This is not harmful, but care should be taken to avoid staining clothing or other items. (UTI Pain Relief only) Stop Use And Ask A Doctor Stop use and ask a doctor if : product has been used for 3 days (UTI Infection Control only) ringing in the ears (UTI Infection Control only) you experience any of the following signs of stomach bleeding: ■ feel faint ■ vomit blood ■ have bloody or black stool ■ have stomach pain or upset that gets worse or lasts (UTI Infection Control only) your symptoms last for more than 2 days (UTI Pain Relief only) you suspect you are having an adverse reaction to the medication (UTI Pain Relief only) Long Term Administration (UTI Pain Relief Only) Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) and mice (liver).

Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted. If Pregnant or Breast Feeding UTI Infection Control If pregnant or breast feeding, ask a health professional before use. It is especially important not to use this product (which contains sodium salicylate) during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

UTI Pain Relief If pregnant or breast feeding, ask a health professional before…

📦 Storage and Handling 96 words ▾

Other Information UTI Infection Control each tablet contains: sodium 24.4 mg store at 59-86°F (15-30°C) in a cool dry place protect from sunlight Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal is open or damaged UTI Pain Relief this product may stain contact lenses this product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light Tamper evident: tablets sealed in blisters.

Do not use if blister foil or seal is open or damaged

🧪 Active Ingredient 31 words ▾

Active ingredients (in each tablet) Purpose Methenamine 162mg Antibacterial Sodium Salicylate 162.5mg (NSAID)* *nonsteroidal anti-inflammatory drug Analgesic (pain reliever) Active ingredient (in each tablet) Purpose Phenazopyridine Hydrochloride 99.5mg Urinary Tract Analgesic

🧪 Inactive Ingredients 65 words ▾

Inactive Ingredients UTI Infection Control benzoic acid, croscarmellose sodium, fd&c red #40, fd&c yellow #6, hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate copolymer, microcrystalline cellulose, silicon dioxide, stearic acid, sodium bicarbonate, sodium lauryl sulfate, talc, titanium dioxide, triacetin, triethyl citrate UTI Pain Relief corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodium starch glycolate, talc and triacetin.

🎯 Purpose 31 words ▾

Active ingredients (in each tablet) Purpose Methenamine 162mg Antibacterial Sodium Salicylate 162.5mg (NSAID)* *nonsteroidal anti-inflammatory drug Analgesic (pain reliever) Active ingredient (in each tablet) Purpose Phenazopyridine Hydrochloride 99.5mg Urinary Tract Analgesic

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 73712-0114-12 · Bonafide 73712-0600-12 · Bonafide →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.